AtriCure (ATRC) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 -1.25%
Revenue Growth %: +11.7%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +11.7%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.01), $0.22 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $49.9 million.
GUIDANCE:
AtriCure sees FY2018 revenue of $193-197 million, versus the consensus of $195 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
